Neoadjuvant and Adjuvant Therapy: Questions Getting Answered

Presented by Dr. Omid Hamid, Co-Director of the Melanoma Research Program at The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate, this insightful presentation delves into the transformative role of neoadjuvant and adjuvant therapies in cancer care, with a focus on melanoma.




Dr. Hamid highlights how ongoing clinical trials and emerging real-world data are addressing critical questions, driving innovation, and refining treatment strategies for improved patient outcomes.




Key Topics Include:





Optimal use of neoadjuvant vs. adjuvant therapies


Impact on recurrence rates and long-term survival


Updates from the latest clinical trials


Role of biomarkers in patient selection


Practical considerations in an evolving therapeutic landscape





Tailored for oncology professionals, researchers, and engaged patients, this presentation provides expert perspectives on how cutting-edge data is redefining standards of care and delivering more personalized treatment options.



Subscribe for more expert-led cancer education and research insights.

#NeoadjuvantTherapy #AdjuvantTherapy #Melanoma #OmidHamidMD #CancerTreatment #Immunotherapy #CedarsSinai #TheAngelesClinic #OncologyResearch #MelanomaCare